David B Jones
Examiner (ID: 17751, Phone: (571)272-4518 , Office: P/3725 )
Most Active Art Unit | 3725 |
Art Unit(s) | 3725, 3201, 2899 |
Total Applications | 4053 |
Issued Applications | 3621 |
Pending Applications | 85 |
Abandoned Applications | 332 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6921527
[patent_doc_number] => 20010029012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Composition and methods for the treatment of cancer and viral infections'
[patent_app_type] => new
[patent_app_number] => 09/835597
[patent_app_country] => US
[patent_app_date] => 2001-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12990
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029012.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835597
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835597 | Composition and methods for the treatment of cancer and viral infections | Apr 15, 2001 | Abandoned |
Array
(
[id] => 1423677
[patent_doc_number] => 06503748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-07
[patent_title] => 'Endogenous ketogulonigenium plasmid'
[patent_app_type] => B2
[patent_app_number] => 09/826205
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3672
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503748.pdf
[firstpage_image] =>[orig_patent_app_number] => 09826205
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/826205 | Endogenous ketogulonigenium plasmid | Apr 4, 2001 | Issued |
Array
(
[id] => 5999938
[patent_doc_number] => 20020028514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Recombinant AAV vector-based transduction system and use of same'
[patent_app_type] => new
[patent_app_number] => 09/773302
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1625
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028514.pdf
[firstpage_image] =>[orig_patent_app_number] => 09773302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/773302 | Recombinant AAV vector-based transduction system and use of same | Jan 29, 2001 | Issued |
Array
(
[id] => 6889352
[patent_doc_number] => 20010024807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Expression vectors, transfection systems, and method of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/748061
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13581
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09748061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/748061 | Expression vectors, transfection systems, and method of use thereof | Dec 21, 2000 | Issued |
Array
(
[id] => 1487467
[patent_doc_number] => 06428961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Nucleic acid molecules encoding histidine tags in three reading frames'
[patent_app_type] => B1
[patent_app_number] => 09/732990
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9926
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/428/06428961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732990
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732990 | Nucleic acid molecules encoding histidine tags in three reading frames | Dec 7, 2000 | Issued |
Array
(
[id] => 5801539
[patent_doc_number] => 20020009799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Isolation and purification of nucleic acids'
[patent_app_type] => new
[patent_app_number] => 09/733240
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9579
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009799.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733240
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733240 | Isolation and purification of nucleic acids | Dec 7, 2000 | Abandoned |
09/728710 | Gene silencing | Nov 30, 2000 | Abandoned |
60/327575 | Reporter gene constructs | Nov 20, 2000 | Pending |
Array
(
[id] => 1453250
[patent_doc_number] => 06461837
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Methods for producing a polypeptide using a consensus translational initiator sequence'
[patent_app_type] => B1
[patent_app_number] => 09/717847
[patent_app_country] => US
[patent_app_date] => 2000-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14591
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461837.pdf
[firstpage_image] =>[orig_patent_app_number] => 09717847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/717847 | Methods for producing a polypeptide using a consensus translational initiator sequence | Nov 19, 2000 | Issued |
Array
(
[id] => 1560860
[patent_doc_number] => 06361975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Mouse aspartic secretase-2(mASP-2)'
[patent_app_type] => B1
[patent_app_number] => 09/713158
[patent_app_country] => US
[patent_app_date] => 2000-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10074
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/361/06361975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09713158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/713158 | Mouse aspartic secretase-2(mASP-2) | Nov 14, 2000 | Issued |
09/692204 | Regulation of promoter activity in cells | Oct 19, 2000 | Abandoned |
Array
(
[id] => 1500081
[patent_doc_number] => 06485971
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'Keratinocyte stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/664437
[patent_app_country] => US
[patent_app_date] => 2000-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 7290
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/485/06485971.pdf
[firstpage_image] =>[orig_patent_app_number] => 09664437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/664437 | Keratinocyte stem cells | Sep 17, 2000 | Issued |
Array
(
[id] => 1377325
[patent_doc_number] => 06555335
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme'
[patent_app_type] => B1
[patent_app_number] => 09/658772
[patent_app_country] => US
[patent_app_date] => 2000-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 15751
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555335.pdf
[firstpage_image] =>[orig_patent_app_number] => 09658772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/658772 | Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme | Sep 10, 2000 | Issued |
Array
(
[id] => 1559389
[patent_doc_number] => 06436665
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Methods for encoding and sorting in vitro translated proteins'
[patent_app_type] => B1
[patent_app_number] => 09/648040
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 7839
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436665.pdf
[firstpage_image] =>[orig_patent_app_number] => 09648040
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/648040 | Methods for encoding and sorting in vitro translated proteins | Aug 24, 2000 | Issued |
Array
(
[id] => 4271912
[patent_doc_number] => 06307037
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Fungal target genes and methods'
[patent_app_type] => 1
[patent_app_number] => 9/625188
[patent_app_country] => US
[patent_app_date] => 2000-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31164
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/307/06307037.pdf
[firstpage_image] =>[orig_patent_app_number] => 625188
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625188 | Fungal target genes and methods | Jul 20, 2000 | Issued |
Array
(
[id] => 1580870
[patent_doc_number] => 06423544
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-23
[patent_title] => 'Compositions and methods for producing recombinant virions'
[patent_app_type] => B1
[patent_app_number] => 09/608730
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 19302
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/423/06423544.pdf
[firstpage_image] =>[orig_patent_app_number] => 09608730
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/608730 | Compositions and methods for producing recombinant virions | Jun 29, 2000 | Issued |
Array
(
[id] => 1414918
[patent_doc_number] => 06518066
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Control of gene expression in eukaryotic cells'
[patent_app_type] => B1
[patent_app_number] => 09/608958
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 28182
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518066.pdf
[firstpage_image] =>[orig_patent_app_number] => 09608958
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/608958 | Control of gene expression in eukaryotic cells | Jun 29, 2000 | Issued |
Array
(
[id] => 4324055
[patent_doc_number] => 06329201
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Compositions and methods for packaging of alphavirus vectors'
[patent_app_type] => 1
[patent_app_number] => 9/609154
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22924
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329201.pdf
[firstpage_image] =>[orig_patent_app_number] => 609154
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/609154 | Compositions and methods for packaging of alphavirus vectors | Jun 29, 2000 | Issued |
Array
(
[id] => 1565272
[patent_doc_number] => 06376216
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Promoter from Ashbya gossypii'
[patent_app_type] => B1
[patent_app_number] => 09/582041
[patent_app_country] => US
[patent_app_date] => 2000-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376216.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582041
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582041 | Promoter from Ashbya gossypii | Jun 20, 2000 | Issued |
Array
(
[id] => 1585130
[patent_doc_number] => 06358733
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Expression of heterologous multi-domain proteins in yeast'
[patent_app_type] => B1
[patent_app_number] => 09/574492
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 14941
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358733.pdf
[firstpage_image] =>[orig_patent_app_number] => 09574492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/574492 | Expression of heterologous multi-domain proteins in yeast | May 18, 2000 | Issued |